Wefas Ayurvedic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 24-12-2024
- Revenue %
(FY 2022)
- Profit -145.29%
(FY 2022)
- Ebitda -6.63%
(FY 2022)
- Net Worth
- Total Assets 224.90%
(FY 2022)
About Wefas Ayurvedic
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Neha Pawar and Sunil Pawar serve as directors at the Company.
- CIN/LLPIN
U36999MH2018PTC315771
- Company No.
315771
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Wefas Ayurvedic Private Limited offer?
Wefas Ayurvedic Private Limited offers a wide range of products and services, including Ayurvedic, Herbal Oils and Cosmetics, Ayurvedic Cosmetics, Ayurvedic Digestive Medicine, Ayurvedic Digestive Powder, Ayurvedic Pain Relief Oil, Muscle Pain Oil, Skin Care Cosmetics, Crack Heal Cream, Fitness Supplements, Sports Nutrition Powder.
Who are the key members and board of directors at Wefas Ayurvedic?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Pawar | Director | 19-Nov-2018 | Current |
Neha Pawar | Director | 15-Oct-2018 | Current |
Financial Performance of Wefas Ayurvedic.
Wefas Ayurvedic Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 145.29% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth | |||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Wefas Ayurvedic?
Unlock access to Wefas Ayurvedic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 14 Jul 2023 | ₹1.00 M | Open |
How Many Employees Work at Wefas Ayurvedic?
Unlock and access historical data on people associated with Wefas Ayurvedic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wefas Ayurvedic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wefas Ayurvedic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.